Release Date: 16/07/15 16:49 Summary: Notice that remaining conditions to takeover bid freed Price Sensitive: Yes Download Document 228.5KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling